Autosomal dominant cerebellar ataxia, deafness, and narcolepsy

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Autosomal dominant cerebellar ataxia, deafness, and narcolepsy
Synonyms ADCADN
Pronounce N/A
Specialty Neurology, Genetics
Symptoms Cerebellar ataxia, Hearing loss, Narcolepsy
Complications N/A
Onset Adulthood
Duration Chronic
Types N/A
Causes Genetic mutation
Risks Family history
Diagnosis Genetic testing, Clinical evaluation
Differential diagnosis Multiple system atrophy, Spinocerebellar ataxia
Prevention N/A
Treatment Symptomatic treatment, Physical therapy, Hearing aids
Medication N/A
Prognosis Variable
Frequency Rare disease
Deaths N/A


Other Names: ADCADN; ADCA-DN; Autosomal dominant cerebellar ataxia, deafness and narcolepsy; Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome; ADCA-DN syndrome A rare polymorphic disorder, subtype of autosomal dominant cerebellar ataxia type 1 (ADCA type 1), characterized by ataxia, sensorineural deafness and narcolepsy with cataplexy and dementia.

Epidemiology[edit]

ADCA-DN has been reported in 24 patients to date from Sweden, the United States, Italy and Brazil.

Cause[edit]

ADCA-DN is caused by a mutation in the DNA methyltransferase (DNMT1) gene located on chromosome 19p13.2. It encodes an enzyme essential for the repression of transcriptional activity in numerous postmitotic cells.

Inheritance[edit]

ADCA-DN is inherited autosomal dominantly and genetic counseling is possible. Sporadic cases have also been reported.

Signs and symptoms[edit]

Disease onset occurs in adulthood (from the ages of 30-40) with the onset of cerebellar ataxia, narcolepsy with cataplexy, sensorineural deafness and dementia. Optic atrophy, cataracts, psychosis, depression, sensory neuropathy, pseudobulbar signs, incontinence and limb lymphedema have also been reported but present later in the disease course. Mild brain atrophy with cerebellum involvement is visible with magnetic resonance imaging (MRI).

NIH genetic and rare disease info[edit]

Autosomal dominant cerebellar ataxia, deafness, and narcolepsy is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.